492 related articles for article (PubMed ID: 22085817)
1. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.
Lai SW; Chen PC; Liao KF; Muo CH; Lin CC; Sung FC
Am J Gastroenterol; 2012 Jan; 107(1):46-52. PubMed ID: 22085817
[TBL] [Abstract][Full Text] [Related]
2. Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan.
Lai SW; Muo CH; Liao KF; Sung FC; Chen PC
Am J Gastroenterol; 2011 Sep; 106(9):1697-704. PubMed ID: 21577242
[TBL] [Abstract][Full Text] [Related]
3. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan.
Inoue M; Yoshimi I; Sobue T; Tsugane S;
J Natl Cancer Inst; 2005 Feb; 97(4):293-300. PubMed ID: 15713964
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
[TBL] [Abstract][Full Text] [Related]
5. High incidence of hepatocellular carcinoma in ESRD patients: caused by high hepatitis rate or 'uremia'? a population-based study.
Hwang JC; Weng SF; Weng RH
Jpn J Clin Oncol; 2012 Sep; 42(9):780-6. PubMed ID: 22782961
[TBL] [Abstract][Full Text] [Related]
6. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon.
Ikeda M; Fujiyama S; Tanaka M; Sata M; Ide T; Yatsuhashi H; Watanabe H
J Gastroenterol; 2005 Feb; 40(2):148-56. PubMed ID: 15770398
[TBL] [Abstract][Full Text] [Related]
8. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
El-Serag HB; Richardson PA; Everhart JE
Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
[TBL] [Abstract][Full Text] [Related]
9. Risk of developing sudden sensorineural hearing loss in diabetic patients: a population-based cohort study.
Lin SW; Lin YS; Weng SF; Chou CW
Otol Neurotol; 2012 Dec; 33(9):1482-8. PubMed ID: 23064384
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
11. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.
Giordano TP; Kramer JR; Souchek J; Richardson P; El-Serag HB
Arch Intern Med; 2004 Nov; 164(21):2349-54. PubMed ID: 15557414
[TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.
Lai MS; Hsieh MS; Chiu YH; Chen TH
Hepatology; 2006 Jun; 43(6):1295-302. PubMed ID: 16729295
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan.
Lai SW; Liao KF; Chen PC; Tsai PY; Hsieh DP; Chen CC
Clin Lung Cancer; 2012 Mar; 13(2):143-8. PubMed ID: 22129971
[TBL] [Abstract][Full Text] [Related]
14. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
[TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma.
Huo TI; Hsu CY; Huang YH; Hsia CY; Lin HC; Lee PC; Loong CC; Chiang JH; Chiou YY; Lee SD
Liver Int; 2010 Feb; 30(2):198-207. PubMed ID: 19849777
[TBL] [Abstract][Full Text] [Related]
16. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
[TBL] [Abstract][Full Text] [Related]
17. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.
Chang MH; You SL; Chen CJ; Liu CJ; Lee CM; Lin SM; Chu HC; Wu TC; Yang SS; Kuo HS; Chen DS;
J Natl Cancer Inst; 2009 Oct; 101(19):1348-55. PubMed ID: 19759364
[TBL] [Abstract][Full Text] [Related]
18. Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus.
Konishi I; Hiasa Y; Shigematsu S; Hirooka M; Furukawa S; Abe M; Matsuura B; Michitaka K; Horiike N; Onji M
Liver Int; 2009 Sep; 29(8):1194-201. PubMed ID: 19422477
[TBL] [Abstract][Full Text] [Related]
19. Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders.
Imai Y; Tamura S; Tanaka H; Hiramatsu N; Kiso S; Doi Y; Inada M; Nagase T; Kitada T; Imanaka K; Fukuda K; Takehara T; Kasahara A; Hayashi N
J Viral Hepat; 2010 Mar; 17(3):185-91. PubMed ID: 19709362
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study.
Huo TI; Lui WY; Huang YH; Chau GY; Wu JC; Lee PC; Chang FY; Lee SD
Am J Gastroenterol; 2003 Oct; 98(10):2293-8. PubMed ID: 14572582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
